Clinician-reported changes in octreotide prescribing for malignant bowel obstruction as a result of an adequately powered phase III study: A transnational, online survey
SAGE Palliative Medicine & Chronic Care podcast
JULY 12, 2018
This episode features Professor David Currow (University of Technology Sydney, Ultimo, NSW, Australia. Wolfson Palliative Care Research Centre, University of Hull, Hull, UK). This transnational online survey aimed to determine the impact of a phase III randomised controlled trial on palliative care clinicians’ self-reported practice change. The orginal study in question described the use of octreotide in the management of inoperable malignant bowel obstruction.
40 
Let's personalize your content